Gadolinium-labeled quantum dots for molecular magnetic resonance imaging: R1 versus R2 mapping

Magnetic Resonance in Medicine

Volumn 64, Issue 1, 2010, Pages 291-298

  Oostendorp, Marlies ^a,b   Douma, Kim ^a,b   Hackeng, Tilman M ^a,b   Post, Mark J ^a,b,d   Van Zandvoort, Marc A M J ^a,b   Backes, Walter H ^a,b,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Angiogenesis; Molecular MRI; Quantum dots; R1; R2

Indexed keywords

FLUORESCENCE MICROSCOPY; GADOLINIUM; GRAPHENE QUANTUM DOTS; MAGNETIC RESONANCE IMAGING; MAGNETISM; MAPPING; NANOCRYSTALS; SEMICONDUCTOR QUANTUM DOTS;

ANGIOGENESIS; CONTRAST ENHANCEMENT; GADOLINIUM CHELATES; HIGH MAGNETIC FIELDS; LONGITUDINAL RELAXATION; MOLECULAR MRIS; RELAXATION RATES; TRANSVERSE RELAXATION RATE;

MOLECULAR IMAGING;

GADOLINIUM; QUANTUM DOT; CONTRAST MEDIUM;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; LONGITUDINAL STUDY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; STRENGTH; VASCULARIZATION; ANIMAL; KIDNEY; LIVER; NEOPLASMS; NUDE MOUSE; PROCEDURES; RADIOGRAPHY; SPLEEN;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; KIDNEY; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; NEOPLASMS; QUANTUM DOTS; SPLEEN;

EID: 77953953896     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22342     Document Type: Article

References (39)

1. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-333.
2. Winter PM, Caruthers SD, Wickline SA, Lanza GM. Molecular imaging by MRI. Curr Cardiol Rep 2006;8:65-69.
3. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998;4:623-626.
4. Mulder WJ, Cormode DP, Hak S, Lobatto ME, Silvera S, Fayad ZA. Multimodality nanotracers for cardiovascular applications. Nat Clin Pract Cardiovasc Med 2008;5(suppl 2):S103-111.
5. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998;281:2016-2018.
6. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307:538-544.
7. Bakalova R, Zhelev Z, Aoki I, Kanno I. Designing quantum-dot probes. Nat Photonics 2007;1:487-489.
8. Fu AH, Gu WW, Larabell C, Alivisatos AP. Semiconductor nanocrystals for biological imaging. Curr Opin Neurobiol 2005;15:568-575.
9. Oostendorp M, Douma K, Hackeng TM, Dirksen A, Post MJ, van Zandvoort MA, Backes WH. Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. Cancer Res 2008;68:7676-7683.
10. Kok RJ, Schraa AJ, Bos EJ, Moorlag HE, Asgeirsdottir SA, Everts M, Meijer DK, Molema G. Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics. Bioconjug Chem 2002;13:128-135.
11. Mulder WJ, Koole R, Brandwijk RJ, Storm G, Chin PT, Strijkers GJ, de Mello Donega C, Nicolay K, Griffioen AW. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 2006;6:1-6.
12. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, Tang CY, Gordon RE, Nicolay K, Meijerink A, Fayad ZA, Mulder WJ. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 2008;8:2517-2525.
13. van Tilborg GA, Mulder WJ, Chin PT, Storm G, Reutelingsperger CP, Nicolay K, Strijkers GJ. Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem 2006;17:865-868. (Pubitemid 44162601)
14. Prinzen L, Miserus RJ, Dirksen A, Hackeng TM, Deckers N, Bitsch NJ, Megens RT, Douma K, Heemskerk JW, Kooi ME, Frederik PM, Slaaf DW, van Zandvoort MA, Reutelingsperger CP. Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots. Nano Lett 2007;7:93-100.
15. Manninen A, Koskinen M, Reimann SM, Mottelson B. Magnetic properties of quantum dots and rings. Eur Phys J D 2001;16:381-385.
16. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Introductory signal acquisition methods: free induction decay, spin echoes, inversion recovery and spectroscopy: magnetic resonance imaging physical principles and sequence design. New York: John Wiley & Sons, Inc.; 1999. pp 111-138.
17. Caravan P, Farrar CT, Frullano L, Uppal R. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging 2009;4:89-100.
18. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys 1984;11:425-448.
19. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54:507-512.
20. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, Claussen CD, Schick F. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 tesla. Invest Radiol 2006;41:213-221.
21. Rinck PA, Muller RN. Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents. Eur Radiol 1999;9:998-1004.
22. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-380. (Pubitemid 28063372)
23. Curnis F, Arrigoni G, Sacchi A, Fischetti L, Arap W, Pasqualini R, Corti A. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res 2002;62:867-874. (Pubitemid 34126966)
24. Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, Ashmun RA, Shapiro LH, Arap W, Ruoslahti E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000;60:722-727. (Pubitemid 30094573)
25. Schnolzer M, Alewood P, Jones A, Alewood D, Kent SB. In situ neutralization in Boc-chemistry solid phase peptide synthesis: rapid, high yield assembly of difficult sequences. Int J Pept Protein Res 1992;40:180-193.
26. Dirksen A, Langereis S, de Waal BFM, van Genderen MHP, Hackeng TM, Meijer EW. A supramolecular approach to multivalent targetspecific MRI contrast agents for angiogenesis. Chem Commun 2005;22:2811-2813. (Pubitemid 40904162)
27. Dirksen A, Meijer EW, Adriaens W, Hackeng TM. Strategy for the synthesis of multivalent peptide-based nonsymmetric dendrimers by native chemical ligation. Chem Commun (Camb) 2006;15:1667-1669.
28. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 1997;16:187-198. (Pubitemid 127762930)
29. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191-200.
30. de Lussanet QG, Beets-Tan RG, Backes WH, van der Schaft DW, van Engelshoven JM, Mayo KH, Griffioen AW. Dynamic contrast-enhanced magnetic resonance imaging at 1.5 tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice. Eur J Cancer 2004;40:1262-1268.
31. Padhani AR. Functional MRI for anticancer therapy assessment. Eur J Cancer 2002;38:2116-2127. (Pubitemid 35223249)
32. Mulder WJ, Strijkers GJ, Habets JW, Bleeker EJ, van der Schaft DW, Storm G, Koning GA, Griffioen AW, Nicolay K. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005;19:2008-2010. (Pubitemid 41759747)
33. de Lussanet QG, Backes WH, Griffioen AW, van Engelshoven JM, Beets-Tan RG. Gadopentetate dimeglumine versus ultrasmall super-paramagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice. Radiology 2003;229:429-438.
34. Gambarota G, van Laarhoven HW, Philippens M, Lok J, van der Kogel A, Punt CJ, Heerschap A. Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI. Magn Reson Imaging 2006;24:279-286.
35. Corti A, Curnis F, Arap W, Pasqualini R. The neovasculature homing motif NGR: more than meets the eye. Blood 2008;112:2628-2635.
36. Dockery SE, Suddarth SA, Johnson GA. Relaxation measurements at 300 MHz using MR microscopy. Magn Reson Med 1989;11:182-192.
37. Streif JU, Hiller KH, Waller C, Nahrendorf M, Wiesmann F, Bauer WR, Rommel E, Haase A. In vivo assessment of absolute perfusion in the murine skeletal muscle with spin labeling MRI: magnetic resonance imaging. J Magn Reson Imaging 2003;17:147-152.
38. Cremillieux Y, Ding S, Dunn JF. High-resolution in vivo measurements of transverse relaxation times in rats at 7 tesla. Magn Reson Med 1998;39:285-290. (Pubitemid 28099147)
39. Guilfoyle DN, Dyakin VV, O'shea J, Pell GS, Helpern JA. Quantitative measurements of proton spin-lattice (T1) and spin-spin (T2) relaxation times in the mouse brain at 7.0 T. Magn Reson Med 2003;49:576-580.